Penumbra(PEN) - 2024 Q2 - Earnings Call Transcript

So, Pito, the 23% to 25% for U.S. thrombectomy is an annual number. And so, what that implies for the third and fourth quarter year-over-year growth respectively, is about the same, about 20% growth on a year-over-year basis. Adam Elsesser Pito Chickering Adam Elsesser Jason Mills Penumbra, Inc. (NYSE:PEN) Q2 2024 Earnings Conference Call July 30, 2024 4:30 PM ET Company Participants Cecilia Furlong - Director of Business Development and Investor Relations Adam Elsesser - Chairman and Chief Executive Office ...